Dr. Crilley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2 Capital Way
Ste 220
Pennington, NJ 08534Phone+1 609-303-0747Fax+1 609-303-0771
Summary
- Dr. Pamela Crilley is an oncologist in Pennington, NJ and is affiliated with Capital Health Medical Center-Hopewell. She received her medical degree from Philadelphia College of Osteopathic Medicine and has been in practice 38 years. She specializes in breast cancer, genitourinary oncology, and hematologic oncology and is experienced in non-hodgkin lymphoma, breast cancer, genitourinary cancer, myeloproliferative disorders, and hodgkin's lymphoma. She has more than 50 publications and over 500 citings.
Education & Training
- Jefferson Health NortheastResidency, Internal Medicine, 1979 - 1982
- Philadelphia College of Osteopathic MedicineClass of 1979
Certifications & Licensure
- PA State License 1980 - 2026
- NJ State License 2021 - 2025
- IL State License 2013 - 2014
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
Clinical Trials
- Combination Plerixafor (AMD3100)and Bortezomib in Relapsed or Relapsed/Refractory Multiple Myeloma Start of enrollment: 2009 Jun 01
Publications & Presentations
PubMed
- 214 citationsNonmyeloablative HLA-Haploidentical Bone Marrow Transplantation with High-Dose Posttransplantation Cyclophosphamide: Effect of HLA Disparity on OutcomeYvette L. Kasamon, Leo Luznik, Mary S. Leffell, Jeanne Kowalski, Hua Ling Tsai
Biology of Blood and Marrow Transplantation. 2010-04-01 - 365 citationsConventional-dose chemotherapy compared with high-dose chemotherapy plus autologous hematopoietic stem-cell transplantation for metastatic breast cancerEdward A. Stadtmauer, Anne O'Neill, Lori J. Goldstein, Pamela Crilley, Mangan Kf
The New England Journal of Medicine. 2000-04-13 - 32 citationsCetuximab in Patients with Breast Cancer, Non-Small Cell Lung Cancer, and Ovarian Cancer Without KRAS, NRAS, or BRAF Mutations: Results from the Targeted Agent and Pro...Julie Gottlieb Fisher, David Tait, Elizabeth Garrett-Mayer, Susan Halabi, Pam K. Mangat
Targeted Oncology. 2020-10-22
Press Mentions
- Even During Pandemic, Cancer Screenings Remain VitalOctober 7th, 2020
- People Donate Life-Saving Blood, Bone Marrow at CTCASeptember 30th, 2019
- 16 Things You're Getting Wrong About Cancer, According to ExpertsFebruary 7th, 2019
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: